Clinical and Dosimetric Predictors of Late Rectal Syndrome After 3D-CRT for Localized Prostate Cancer: Preliminary Results of a Multicenter Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 4, 2008, Pages 1130-1137

  Fiorino, Claudio ^a   Fellin, Gianni ^b   Rancati, Tiziana ^c   Vavassori, Vittorio ^d   Bianchi, Carla ^d   Borca, Valeria Casanova ^e   Girelli, Giuseppe ^e   Mapelli, Marco ^f   Menegotti, Loris ^b   Nava, Simona ^f   Valdagni, Riccardo ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

^e Ospedale di Ivrea   (Italy)

^f Policlinico   (Italy)

Author keywords

Conformal radiotherapy; Late toxicity; Prostate radiotherapy; Rectal syndrome

Indexed keywords

CONFORMAL MAPPING; DOSIMETRY; PATIENT MONITORING; RADIOTHERAPY; SURGERY; TOXICITY;

CONFORMAL RADIOTHERAPY; LATE TOXICITY; PROSTATE RADIOTHERAPY; RECTAL SYNDROME;

ONCOLOGY;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FECES INCONTINENCE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RECTUM HEMORRHAGE; RISK ASSESSMENT; TENESMUS;

ABDOMEN; ANALYSIS OF VARIANCE; CONSTIPATION; DEFECATION; FECAL INCONTINENCE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; ODDS RATIO; PELVIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECTUM;

EID: 39749118187     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.07.2354     Document Type: Article

References (32)

1. Boersma L.J., van den Brink M., Allison M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
2. Skwarchuk M.W., Jackson A., Zelefsky M.J., et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose response. Int J Radiat Oncol Biol Phys 47 (2000) 103-113
3. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
4. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: Analysis of a large group of patients pooled from three institutions. Radiother Oncol 64 (2002) 1-12
5. Huang E.H., Pollack A., Levy L., et al. Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 1009-1019
6. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late rectal bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 55 (2003) 688-694
7. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
8. Zapatero A., Garcia-Vicente F., Modolell I., et al. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: Dose-volume effect. Int J Radiat Oncol Biol Phys 59 (2004) 1343-1351
9. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS 0101). Radiother Oncol 73 (2004) 21-32
10. Vargas C., Martinez A., Kestin L.L., et al. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 1297-1308
11. Peeters S.T.H., Lebesque J.V., Heemsbergen W.D., et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1151-1161
12. Peeters S.T.H., Hoogeman M., Heemsbergen W.D., et al. Rectal bleeding, fecal incontinence and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 66 (2006) 11-19
13. Söhn M., Yan D., Liang J., et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 67 (2007) 1066-1073
14. Marzi S., Arcangeli G., Saracino B., et al. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. Int J Radiat Oncol Biol Phys 68 (2007) 41-49
15. Davidson S.E., Burns M., Routledge J., et al. A morbidity scoring system for clinical oncology practice: Questionnaires produced from the LENT SOMA scoring system. Clin Oncol 14 (2002) 68-69
16. Vavassori V., Fiorino C., Rancati T., et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: Results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 66 (2007) 1401-1410
17. Fiorino C., Gianolini S., and Nahum A.E. A cylindrical model of the rectum: Comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Phys Med Biol 48 (2003) 2603-2616
18. Monti A., Baccolini M., Fellin G., et al. The impact of set-up error on quality control of a multi-centric study on rectal toxicity during 3D-CRT of prostate cancer (AIROPROS 0102). Radiother Oncol 81 Suppl. 1 (2006) S456-S457
19. Foppiano F., Fiorino C., Frezza G., et al. The impact of contouring uncertainty on rectal 3D dose-volume data: Results of a dummy run in a multicenter trial (AIROPROS 01-02). Int J Radiat Oncol Biol Phys 57 (2003) 573-579
20. Declich F., Fiorino C., Masi L., et al. Comparing rectal DVH calculation with four commercial treatment planning systems by means of the AAPM TG23 18 MV. [Abstract]. Radiother Oncol 64 Suppl. 1 (2002) S318
21. Peeters S.T., Hoogeman M.S., Heemsbergen W.D., et al. Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
22. Smit W.G., Helle P.A., van Putten W.L., et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 18 (1990) 23-29
23. Liu M., Pickles T., Agranovich A., et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 59-67
24. Herold D.M., Hanlon A.L., and Hanks G.E. Diabetes mellitus: A predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43 (1999) 475-479
25. Denham J.W., and Hauer-Jensen M. The radiotherapeutic injury-a complex "wound.". Radiother Oncol 63 (2002) 129-145
26. Zelefsky M.J., and Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy. Urology 49 3A Suppl. (1997) 38-45
27. Tsai H.K., Manola J., Abner A., et al. Patient-reported acute gastrointestinal toxicity in men receiving 3-dimensional conformal radiation therapy for prostate cancer with or without neoadjuvant androgen suppression therapy. Urol Oncol 23 (2005) 230-237
28. Valicenti R.K., Winter K., Cox J.D., et al. RTOG 94-06: Is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?. Int J Radiat Oncol Biol Phys 57 (2003) 614-620
29. Zapatero A., Alcantara P., Valcarcel F., et al. Preliminary report of a multicenter Spanish trial (GICOR 05) of risk-adapted androgen ablation combined with dose-escalation 3D conformal therapy for prostate cancer: Impact on early toxicity. [Abstract]. Int J Radiat Oncol Biol Phys 57 Suppl. 1 (2003) S391-S392
30. Lilleby W., Dale E., Olsen D.R., et al. Changes in treatment volume of hormonally treated and untreated cancerous prostate and its impact on rectal dose. Acta Oncol 42 (2003) 10-14
31. Sanguineti G., Marcenaro M., Franzone P., et al. Neoadjuvant androgen deprivation and prostate gland shrinkage during conformal radiotherapy. Radiother Oncol 66 (2003) 151-157
32. Heemsbergen W.D., Hoogeman M.S., Hart G.A., et al. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1011-1018